Toboroz
A Study of Rusfertide in Japanese Adults With Polycythemia Vera
NCT07648030· 2. fázis· Takeda· Forrás
Toboroz
Safety, Dosage, and Microbiome Engraftment Study of MGT-006 for Ulcerative Colitis (ROOT Study)
NCT07913347· 1/2. fázis· Metagen Therapeutics, Inc.· Forrás
Contact: Metagen Therapeutics Clinical development devision
Toboroz
A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC PFS in Adult Participants With Graves' Disease.
NCT07596849· 3. fázis· argenx· Forrás
Contact: Toyoyoshi Uchida, MD
Toboroz
A Study to Assess How Well and Safely Elafibranor Works in Adult Participants With Primary Sclerosing Cholangitis
NCT07387549· 3. fázis· Ipsen· Forrás
Contact: Ipsen Clinical Study Enquiries
Toboroz
A Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents
NCT07424404· 3. fázis· Karuna Therapeutics, Inc., a Bristol Myers Squibb company· Forrás
Contact: Akane Yoshikawa, Site 0086
Toboroz
A Study of ASP2246 for People Who Have Movement Problems Caused by Brain Injury After a Stroke
NCT07318714· 1/2. fázis· Astellas Pharma Inc· Forrás
Contact: Astellas Pharma Inc.
Toboroz
A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (EMERGENT TEEN)
NCT07288567· 3. fázis· Bristol-Myers Squibb· Forrás
Contact: Akane Yoshikawa, Site 0086
Toboroz
A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)
NCT06405087· 3. fázis· Takeda· Forrás
Contact: Takahiro Kudo (principal investigator)
Toboroz
A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or Lamotrigine
NCT07140913· 3. fázis· Bristol-Myers Squibb· Forrás
Contact: Tadafumi Kato, Site 0180
Toboroz
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
NCT07062965· 3. fázis· Pfizer· Forrás
Toboroz
A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)
NCT06929273· 3. fázis· Bristol-Myers Squibb· Forrás
Contact: Tadafumi Kato, Site 0163
Toboroz
A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy
NCT06963827· 3. fázis· Takeda· Forrás
Contact: Yusuke Suzuki (principal investigator)
Fut, nem toboroz
A Study of CC-97540 (BMS-986353 or Zola-cel), CD19-Targeted NEX-T CAR T Cells, in Participants With Active SLE Despite Immunosuppressants (Breakfree-SLE)
NCT07015983· 2. fázis· Juno Therapeutics, Inc., a Bristol-Myers Squibb Company· Forrás
Toboroz
REGN7508 Versus Apixaban and Enoxaparin for Thromboprophylaxis After Total Knee Arthroplasty in Adults
NCT07015905· 3. fázis· Regeneron Pharmaceuticals· Forrás
Contact: Clinical Trials Administrator
Toboroz
ANCHOR Study: A Study to Assess the Safety and Efficacy of ABBV-CLS-628 in Adult Participants With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
NCT06902558· 2. fázis· Calico Life Sciences LLC· Forrás
Contact: Calico Clinical Trial Communication
Toboroz
Non-antithrombotic Versus. Single Antiplatelet Therapy Following Left Atrial Appendage Closure
NCT07125417· 4. fázis· OCEAN-SHD Study Group· Forrás
Contact: Shinya Okazaki
Toboroz
A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN)
NCT06935357· 3. fázis· Biogen· Forrás
Contact: US Biogen Clinical Trial Center
Toboroz
A Study to Compare TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
NCT06747351· 3. fázis· Takeda· Forrás
Contact: Yuji Tomizawa (principal investigator)
Toboroz
A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease
NCT06100289· 3. fázis· Takeda· Forrás
Contact: Takahiro Kudo (principal investigator)
Fut, nem toboroz
Study of PF-07220060 With Letrozole in Adults With HR-positive HER2-negative Breast Cancer Who Have Not Received Anticancer Treatment for Advanced/Metastatic Disease
NCT06760637· 3. fázis· Pfizer· Forrás
Fut, nem toboroz
Characterization And Clinical Outcomes of AA Patients Treated With Ritlecitinib
NCT06531109· Pfizer· Forrás
Fut, nem toboroz
A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG)
NCT06456580· 3. fázis· Vor Biopharma· Forrás
Fut, nem toboroz
Study Comparing Tarlatamab and Durvalumab Versus Durvalumab Alone in First-Line Extensive-Stage Small-Cell Lung Cancer (ES-SCLC) Following Platinum, Etoposide and Durvalumab
NCT06211036· 3. fázis· Amgen· Forrás
Fut, nem toboroz
Study Evaluating Tarlatamab After Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer (LS-SCLC)
NCT06117774· 3. fázis· Amgen· Forrás
Fut, nem toboroz
Trial of Efficacy and Safety of NS-229 Versus Placebo in Patients With Eosinophilic Granulomatosis With Polyangiitis
NCT06046222· 2. fázis· NS Pharma, Inc.· Forrás
Toboroz
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
NCT05920356· 3. fázis· Amgen· Forrás
Toboroz
A Phase III Study of CLS2901C in Patients With Osteoarthritis of the Knee
NCT06549686· 3. fázis· CellSeed Inc.· Forrás
Contact: Chikako Sato
Toboroz
Post-Marketing Surveillance of Dehydrated Human Amnion/Chorion Membrane (DHACM) in Non-Ischemic Chronic Wounds
NCT06236750· MiMedx Group, Inc.· Forrás
Contact: Chief Medical Officer
Fut, nem toboroz
Study Comparing Tarlatamab With Standard of Care Chemotherapy in Relapsed Small Cell Lung Cancer
NCT05740566· 3. fázis· Amgen· Forrás
Toboroz
A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
NCT05442567· 3. fázis· Takeda· Forrás
Contact: Takahiro Kudo (principal investigator)
Fut, nem toboroz
A Study to Learn About a New Medicine Called Vepdegestrant (ARV-471, PF-07850327) in People Who Have Advanced Metastatic Breast Cancer
NCT05654623· 3. fázis· Pfizer· Forrás
Toboroz
A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis
NCT05287126· 2. fázis· Pfizer· Forrás
Fut, nem toboroz
Study of Dato-DXd Plus Pembrolizumab vs Pembrolizumab Alone in the First-line Treatment of Subjects With Advanced or Metastatic NSCLC Without Actionable Genomic Alterations
NCT05215340· 3. fázis· Daiichi Sankyo· Forrás
Toboroz
A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)
NCT04779320· 3. fázis· Takeda· Forrás
Contact: Takahiro Kudo (principal investigator)
Fut, nem toboroz
Evaluation of Oral Tofacitinib in Children Aged 2 to 17 Years Old Suffering From Moderate to Severe Ulcerative Colitis
NCT04624230· 3. fázis· Pfizer· Forrás
Fut, nem toboroz
An Open-label, Uncontrolled Study of ONO-7913 and ONO-4538 in Combination With Modified FOLFIRINOX Therapy, the Standard of Care, as First-line Treatment in Patients With Metastatic Pancreatic Cancer
NCT06532344· 1. fázis· Ono Pharmaceutical Co., Ltd.· Forrás
Fut, nem toboroz
A Study of Intravenous Vedolizumab Administered Every 4 Weeks in Japanese Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease
NCT04738942· 3. fázis· Takeda· Forrás
Toboroz
Extension Study of P1101 After Completion of Phase 2 Study in PV Patients or Phase 3 Study in ET Patients
NCT04655092· 3. fázis· PharmaEssentia Japan K.K.· Forrás
Contact: Hiroaki Kawase